The Carlat Psychiatry Podcast

How to treat ADHD in bipolar disorder without destabilizing mood part 2: non-stimulants and supplements. CME: Take the CME Post-Test for this Episode Published On: 12/02/2024 Duration: 11 minutes, 01 seconds Chris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

How to treat ADHD in bipolar disorder without destabilizing mood part 1: stimulants and non-stimulants. CME: Take the CME Post-Test for this Episode Published On: 11/25/2024 Duration: 17 minutes, 26 seconds Chris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

You’ll never be 100% sure if a patient has bipolar, ADHD, or both, but we’ll get you as close as we can. CME: Take the CME Post-Test for this Episode Published On: 11/18/2024 Duration: 17 minutes, 24 seconds Chris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Today, we delve into the complicated world of psychiatric diagnoses and their impact on treatment. CME: Take the CME Post-Test for this Episode Published On: 11/11/2024 Duration: 34 minutes, 20 seconds Mark L. Ruffalo, MSW, DPsa and Nassir Ghaemi, MD, MPH, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

How to assess med response when the patient reports is a poor guide: long-term mood stabilizers, sleep meds, and rapid cycling. CME: Take the CME Post-Test for this Episode Published On: 11/04/2024 Duration: 18 minutes, 12 seconds Chris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

A new med combo for alcohol use disorder, antipsychotic dose reduction in schizophrenia, and two new tips for using stimulants in ADHD. CME: Take the CME Post-Test for this Episode Published On: 10/28/2024 Duration: 24 minutes, 12 seconds Chris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

New studies change how we think about lithium and weight gain, and updates on lumateperone, lavender, and esketamine in depression CME: Take the CME Post-Test for this Episode Published On: 10/21/2024 Duration: 24 minutes, 43 seconds Chris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

We count down the top 10 research updates of the past year with a focus on treatment resistant depression and benzo withdrawal. CME: Take the CME Post-Test for this Episode Published On: 10/14/2024 Duration: 19 minutes, 35 seconds Chris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

KarXT (Cobenfy) is the first antipsychotic that doesn’t block dopamine. We trace the origins of this new drug to a South Asian herb used for over 5,000 years, up to the three EMERGENT trials that led to its FDA approval. CME: Take the CME Post-Test for this Episode Published On: 10/07/2024 Duration: 12 minutes, 28 seconds Chris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Today, we are talking about using cognitive behavioral therapy to treat Obsessive-Compulsive Disorder in clinical settings. CME: Take the CME Post-Test for this Episode Published On: 09/30/2024 Duration: 20 minutes, 20 seconds Joshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

A new medication is knocking on the door for FDA approval in PTSD, and it isn’t MDMA. We cover that, and 8 other off label medications. CME: Take the CME Post-Test for this Episode Published On: 09/23/2024 Duration: 27 minutes, 18 seconds Chris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Should we follow the FDA and give SSRIs, or venture off label with the fabled prazosin? CME: Take the CME Post-Test for this Episode Published On: 09/16/2024 Duration: 18 minutes, 35 seconds Chris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Learn what therapies work for PTSD, what goes on in session, and how to prevent PTSD when your patient calls after a trauma. CME: Take the CME Post-Test for this Episode Published On: 09/09/2024 Duration: 16 minutes, 10 seconds Chris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The transition to college can be challenging for any adolescent, but when an adolescent has psychological conditions, or they're dealing with other mental health concerns, it is especially difficult to navigate this transition. CME: Take the CME Post-Test for this Episode Published On: 09/02/2024 Duration: 24 minutes, 47 seconds Joshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Why do some people get PTSD after a trauma and not others? What goes on in the brain during PTSD. CME: Take the CME Post-Test for this Episode Published On: 08/26/2024 Duration: 17 minutes, 38 seconds Chris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Why do some people get PTSD after a trauma and not others? What goes on in the brain during PTSD. CME: Take the CME Post-Test for this Episode Published On: 08/19/2024 Duration: 16 minutes, 03 second Chris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Today, we are talking about dysmorphology and genetic disorders in psychiatry. Dr. Marilyn Jones joins us to help us identify and understand these conditions. Dr. Jones tells us about the prevalence and diagnostic considerations for these conditions, such as 22q and Fragile X. Join us as we talk about the importance of early identification, genetic testing, and strategies for supporting individuals and families affected by these conditions. CME: Take the CME Post-Test for this Episode Published On: 08/12/2024 Duration: 29 minutes, 29 seconds Joshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Research updates on benzo discontinuation, iloperidone in mania, lithium, schizophrenia, ECT, a new circadian psychotherapy, and therapy for multi-trauma PTSD. CME: Take the CME Post-Test for this Episode Published On: 08/05/2024 Duration: 16 minutes, 10 second Chris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The Holmes Report looked at racial, social, and economic biases in psychoanalysis. Beverly Stoute, MD, shares the findings. CME: Take the CME Post-Test for this Episode Published On: 07/29/2024 Duration: 22 minutes, 11 second Chris Aiken, MD, Beverly Stoute, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Beverly Stoute, MD, shares research on the origins of unconscious racial bias. CME: Take the CME Post-Test for this Episode Published On: 07/22/2024 Duration: 11 minutes, 12 second Chris Aiken, MD, Beverly Stoute, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.